Mount Lucas Management LP Abb Vie Inc. Transaction History

Mount Lucas Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $123,786 - $142,558	856 Added 4.62%	19,370 $3.09 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $18,118 - $21,728	-131 Reduced 0.7%	18,514 $2.99 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $37,713 - $43,254	-281 Reduced 1.48%	18,645 $2.5 Million
Q2 2022 Aug 10, 2022	BUY	$137.62 - $174.96 $2.6 Million - $3.31 Million	18,926 New	18,926 $2.9 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Mount Lucas Management LP, based on Form 13F filings with the SEC.

Stay updated on Mount Lucas Management LP with notifications on news.